Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cutaneous toxic effects associated with vemurafenib and inhibition of the BRAF pathway.

Cutaneous toxic effects associated with vemurafenib and inhibition of the BRAF pathway. Arch Dermatol. 2012 May; 148(5):628-33.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.